Patient with metastatic renal cell carcinoma, who was treated with tyrosine kinase inhibitor in first and second line of palliative treatment – case report

04/2020

MUDr. Jiří Navrátil, Ph.D.

Klinika komplexní onkologické péče, Masarykův onkologický ústav, Brno

SUMMARY

Disseminated renal cancer is an incurable disease. The fundamental of treatment is targeted therapy with tyrosine kinase inhibitors (TKI). We present a case report of a polymorbid patient with disseminated renal clear cell carcinoma treated with two lines of TKI with a good response to treatment while a good quality of life.

Key words

renal cell carcinoma, target therapy, hepatopathy, diabetes mellitus, pazopanib, sunitinib